Intradermal vs. Intramuscular Delivery of Influenza Vaccine in Immunocompetent Elders.

Trial Profile

Intradermal vs. Intramuscular Delivery of Influenza Vaccine in Immunocompetent Elders.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 May 2014

At a glance

  • Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 12 Jul 2012 Actual patient number changed from 300 to 257 as reported by ClinicalTrials.gov.
    • 08 Apr 2010 Results published in Clinical Infectious Diseases.
    • 30 Apr 2008 Preliminary results were reported at AGS 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top